Callum J. Cooper

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Complete Genome Sequence of vB_EcoP_SU7, a Podoviridae Coliphage with the Rare C3 Morphotype.

Complete Genome Sequence of vB_EcoP_SU7, a Podoviridae Coliphage with the Rare C3 Morphotype.

Journal: Microorganisms

Published: June 15, 2021

Infection Kinetics and Phylogenetic Analysis of vB_EcoD_SU57, a Virulent T1-Like Drexlerviridae Coliphage.

Infection Kinetics and Phylogenetic Analysis of vB_EcoD_SU57, a Virulent T1-Like Drexlerviridae Coliphage.

Journal: Frontiers in microbiology

Published: May 28, 2020

Corrigendum: Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.

Corrigendum: Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.

Journal: Journal of applied microbiology

Published: May 11, 2018

Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 20, 2018

In vitro activity of a combination of bacteriophages and antimicrobial plant extracts.

In vitro activity of a combination of bacteriophages and antimicrobial plant extracts.

Journal: Letters in applied microbiology

Published: August 28, 2017

Corrigendum: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

Corrigendum: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

Journal: Frontiers in microbiology

Published: November 24, 2016

Response: Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

Response: Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

Journal: Frontiers in microbiology

Published: September 02, 2016

Virulence plasmid stability in environmentally occurring Bacillus anthracis from North East Turkey.

Virulence plasmid stability in environmentally occurring Bacillus anthracis from North East Turkey.

Journal: Antonie van Leeuwenhoek

Published: July 25, 2016

A Partially Purified Acinetobacter baumannii Phage Preparation Exhibits no Cytotoxicity in 3T3 Mouse Fibroblast Cells.

A Partially Purified Acinetobacter baumannii Phage Preparation Exhibits no Cytotoxicity in 3T3 Mouse Fibroblast Cells.

Journal: Frontiers in microbiology

Published: June 06, 2016

Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics.

Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics.

Journal: Frontiers in microbiology

Published: May 27, 2016

Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

Journal: Frontiers in microbiology

Published: December 15, 2015

The Use of Germinants to Potentiate the Sensitivity of Bacillus anthracis Spores to Peracetic Acid.

The Use of Germinants to Potentiate the Sensitivity of Bacillus anthracis Spores to Peracetic Acid.

Journal: Frontiers in microbiology

Published: July 20, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026